May Measure Month 2022 in Italy: A Focus on Fixed-dose Combination, Therapeutic Adherence, and Medical Inertia in a Nationwide Survey
High Blood Pressure & Cardiovascular Prevention · 2024
DOI: 10.1007/s40292-024-00642-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift High Blood Pressure & Cardiovascular Prevention, 2024. Verfasst von Rita Del Pinto und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life, Health and Environmental Sciences, Internal Medicine unit, ESH Excellence Center, S. Salvatore Hospital, University of L'Aquila, …. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension, Medication Adherence, Blood Pressure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Università degli Studi dell’Aquila.
Abstract (Originalsprache)
INTRODUCTION: Hypertension is the main risk factor for cardiovascular diseases (CVD). Notably, only about half of hypertensive patients manage to achieve the recommended blood pressure (BP) control. Main reasons for the persistence of uncontrolled BP during treatment are lack of compliance on the patients' side, and therapeutic inertia on physicians' side. METHODS: During the global BP screening campaign "May Measure Month" (MMM) (May 1st to July 31st, 2022), a nationwide, cross-sectional, opportunistic study endorsed by the Italian Society of Hypertension was conducted on volunteer adults ≥ 18 years to raise awareness of the health issues surrounding high BP. A questionnaire on demographic/clinical features and questions on the use of fixed-dose single-pills for the treatment of hypertension was administered. BP was measured with standard procedures. RESULTS: A total of 1612 participants (mean age 60.0±15.41 years; 44.7% women) were enrolled. Their mean BP was 128.5±18.1/77.1±10.4 mmHg. About half of participants were sedentary, or overweight/obese, or hypertensive. 55.5% individuals with complete BP assessment had uncontrolled hypertension. Most were not on a fixed-dose combination of antihypertensive drugs and did not regularly measure BP at home. Self-reported adherence to BP medications was similar between individuals with controlled and uncontrolled BP (95% vs 95.5%). CONCLUSIONS: This survey identified a remarkable degree of therapeutic inertia and poor patients' involvement in the therapeutic process and its monitoring in the examined population, underlining the importance of prevention campaigns to identify areas of unsatisfactory management of hypertension, to increase risk factors' awareness in the population with the final purpose of reducing cardiovascular risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life, Health and Environmental Sciences, Internal Medicine unit, ESH Excellence Center, S. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
- ESH Excellence Center, University of Brescia, Spedali Riuniti di Brescia, Italy.
- ESH Excellence Center, Sant'Orsola-Malpighi University Hospital, Alma Mater Studiorum University of Bologna, Bologna, Italy.
- San Jacopo Hospital, PIOT San Marcello Pistoiese, Pistoia, Italy.
- ESH Excellence Center, P. Giaccone Hospital, University of Palermo, Palermo, Italy.
- Outpatients Hypertension clinic, Lecce, Italy.
Förderung
- Università degli Studi dell’Aquila
Zitieren
APA
Del Pinto, R., Agabiti Rosei, C., Borghi, C., Cipollini, F., Cottone, S., De Giorgi, G. A., Di Guardo, A., Dugnani, M., Fabris, B., Giannattasio, C., Giacchetti, G., Minuz, P., Mulè, G., Nazzaro, P., Parati, G., Rattazzi, M., Saladini, F., Salvetti, M., Sarzani, R., …, & Muiesan, M. L. (2024). May Measure Month 2022 in Italy: A Focus on Fixed-dose Combination, Therapeutic Adherence, and Medical Inertia in a Nationwide Survey. High Blood Pressure & Cardiovascular Prevention. https://doi.org/10.1007/s40292-024-00642-4
Vancouver
Del Pinto R, Agabiti Rosei C, Borghi C, Cipollini F, Cottone S, De Giorgi GA, et al. May Measure Month 2022 in Italy: A Focus on Fixed-dose Combination, Therapeutic Adherence, and Medical Inertia in a Nationwide Survey. High Blood Pressure & Cardiovascular Prevention. 2024. doi:10.1007/s40292-024-00642-4
BibTeX
@article{DelPinto2024,
author = {Del Pinto, Rita and Agabiti Rosei, Claudia and Borghi, Claudio and Cipollini, Franco and Cottone, Santina and De Giorgi, Giuseppe Antonio and Di Guardo, Antonino and Dugnani, Maurizio and Fabris, Bruno and Giannattasio, Cristina and Giacchetti, Gilberta and Minuz, Pietro and Mulè, Giuseppe and Nazzaro, Pietro and Parati, Gianfranco and Rattazzi, Marcello and Saladini, Francesca and Salvetti, Massimo and Sarzani, Riccardo and Savoia, Carmine and Tocci, Giuliano and Veglio, Franco and Volpe, Massimo and Vulpis, Vito and Baldini, Gianluca and Ferri, Claudio and Muiesan, Maria Lorenza},
title = {May Measure Month 2022 in Italy: A Focus on Fixed-dose Combination, Therapeutic Adherence, and Medical Inertia in a Nationwide Survey},
journal = {High Blood Pressure & Cardiovascular Prevention},
year = {2024},
doi = {10.1007/s40292-024-00642-4}
}
EUVIMED